Homology Medicines, Inc. (0T6G.L)
USD 3.22
(-5.26%)
USD 3.22
(-5.26%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | -6.65 Million | 3.2 Million | 33.97 Million | 2.7 Million | 1.66 Million | 5.32 Million |
| Cost of Revenue | 578 Thousand | 2.59 Million | 9.54 Million | 100.39 Million | 89.39 Million | 47.94 Million |
| Gross Profit | -7.22 Million | 609 Thousand | 24.42 Million | -97.69 Million | -87.73 Million | -42.62 Million |
| Operating Expenses | 9.87 Million | 133.88 Million | 120.37 Million | 124.06 Million | 105.29 Million | 63.95 Million |
| Selling, General and Administrative Expenses | 9.87 Million | 35.53 Million | 27.29 Million | 23.66 Million | 15.89 Million | 16.01 Million |
| Research and Development Expenses | 31.72 Million | 98.35 Million | 93.08 Million | 100.39 Million | 89.39 Million | 47.94 Million |
| Other Expenses | -31.72 Million | - | - | - | - | - |
| Cost and Expenses | 41.6 Million | 136.48 Million | 129.91 Million | 132.96 Million | 111.6 Million | 65.24 Million |
| Operating Income | -48.25 Million | -133.28 Million | -95.94 Million | -130.26 Million | -109.94 Million | -59.92 Million |
| Interest Expense | - | - | - | - | - | - |
| Income Tax Expense | 318 Thousand | 715 Thousand | 547 Thousand | -1.00 | - | 1.12 Million |
| Earnings before Tax | -53.42 Million | 1.19 Million | -95.76 Million | -128.69 Million | -103.91 Million | -55.57 Million |
| Net Income | -53.74 Million | -5 Million | -95.76 Million | -128.69 Million | -103.91 Million | -55.57 Million |
| Earnings Per Share Basic | -7.41 | -1.57 | -31.18 | -50.46 | -44.41 | -35.04 |
| Earnings Per Share Diluted | -7.41 | -1.57 | -31.18 | -50.46 | -44.41 | -35.04 |
| Weighted Average Shares Outstanding | 7.25 Million | 3.18 Million | 3.07 Million | 2.55 Million | 2.33 Million | 1.58 Million |
| Weighted Average Shares Outstanding (Diluted) | 7.25 Million | 3.18 Million | 3.07 Million | 2.55 Million | 2.33 Million | 1.58 Million |
| Gross Margin | 1.09 | 0.19 | 0.72 | -36.15 | -52.66 | -8.01 |
| EBIT Margin | 7.18 | -40.74 | -2.54 | -44.91 | -62.20 | -11.02 |
| Profit Margin | 8.08 | -1.56 | -2.82 | -47.63 | -62.37 | -10.44 |
| EBITDA | -47.75 Million | 3.79 Million | -86.22 Million | -119.79 Million | -103.62 Million | -58.63 Million |
| Earnings Before Tax Margin | 7.26 | -41.55 | -2.82 | -48.21 | -65.99 | -11.26 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | - | 1.15 Million | -14.66 Million | - | 354 Thousand |
| Cost of Revenue | 13.41 Million | 123 Thousand | 578 Thousand | 8.33 Million | 136 Thousand | 564 Thousand |
| Gross Profit | -13.41 Million | -123 Thousand | 578 Thousand | -23 Million | -136 Thousand | -210 Thousand |
| Operating Expenses | 4.5 Million | 14.72 Million | 92.68 Million | 9.41 Million | 24.22 Million | 30.6 Million |
| Selling, General and Administrative Expenses | 4.5 Million | 4.87 Million | - | 7.9 Million | 6.7 Million | 7.62 Million |
| Research and Development Expenses | 13.41 Million | 9.84 Million | - | 1.51 Million | 17.51 Million | 22.98 Million |
| Other Expenses | -13.41 Million | - | - | - | - | - |
| Cost and Expenses | 17.91 Million | 14.84 Million | 93.25 Million | 9.41 Million | 24.36 Million | 31.17 Million |
| Operating Income | -17.91 Million | -14.84 Million | -92.1 Million | -9.41 Million | -24.36 Million | -30.81 Million |
| Interest Expense | 1.7 Million | 500 Thousand | - | - | - | - |
| Income Tax Expense | 1.44 Million | 176 Thousand | 318 Thousand | 253 Thousand | 3.37 Million | 5.73 Million |
| Earnings before Tax | -15.52 Million | 1.2 Million | -87.08 Million | -2.15 Million | -29.57 Million | -29.3 Million |
| Net Income | -16.97 Million | 1.02 Million | -112.96 Million | -16.11 Million | -32.95 Million | -35.04 Million |
| Earnings Per Share Basic | -1.42 | 0.32 | - | -5.00 | -10.25 | -10.91 |
| Earnings Per Share Diluted | -1.42 | 0.32 | - | -5.00 | -10.25 | -10.91 |
| Weighted Average Shares Outstanding | 11.95 Million | 3.22 Million | 3.21 Million | 3.22 Million | 3.21 Million | 3.21 Million |
| Weighted Average Shares Outstanding (Diluted) | 11.96 Million | 3.22 Million | 3.21 Million | 3.22 Million | 3.21 Million | 3.21 Million |
| Gross Margin | - | - | 0.50 | 1.57 | - | -0.59 |
| EBIT Margin | - | - | - | 0.64 | - | -85.46 |
| Profit Margin | - | - | -97.72 | 1.10 | - | -98.99 |
| EBITDA | -17.79 Million | -14.72 Million | - | -9.41 Million | -24.22 Million | -30.25 Million |
| Earnings Before Tax Margin | - | - | -79.67 | 0.64 | - | -87.05 |
688599
ELL
6565
AONNY
MCHOY
APT